OTC:CLVLF | News | Clinuvel Pharmaceuticals Ltd

CLVLF News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-08-27Foreign issuer reportSEC filingClinuvel Pharmaceuticals Ltd filed Form 6-KClinuvel Pharmaceuticals Ltd filed Form 6-K.
2026-08-20Foreign issuer reportSEC filingClinuvel Pharmaceuticals Ltd filed Form 6-KClinuvel Pharmaceuticals Ltd filed Form 6-K.
2026-08-12Foreign issuer reportSEC filingClinuvel Pharmaceuticals Ltd filed Form 6-KClinuvel Pharmaceuticals Ltd filed Form 6-K.
2026-07-30Foreign issuer reportSEC filingClinuvel Pharmaceuticals Ltd filed Form 6-KClinuvel Pharmaceuticals Ltd filed Form 6-K.
2026-07-28Foreign issuer reportSEC filingClinuvel Pharmaceuticals Ltd filed Form 6-KClinuvel Pharmaceuticals Ltd filed Form 6-K.
2026-07-27Foreign issuer reportSEC filingClinuvel Pharmaceuticals Ltd filed Form 6-KClinuvel Pharmaceuticals Ltd filed Form 6-K.
2026-07-23Foreign issuer reportSEC filingClinuvel Pharmaceuticals Ltd filed Form 6-KClinuvel Pharmaceuticals Ltd filed Form 6-K.
2026-07-22Foreign issuer reportSEC filingClinuvel Pharmaceuticals Ltd filed Form 6-KClinuvel Pharmaceuticals Ltd filed Form 6-K.
2026-07-22Foreign issuer reportSEC filingClinuvel Pharmaceuticals Ltd filed Form 6-KClinuvel Pharmaceuticals Ltd filed Form 6-K.